GDF15 and Anorexia: Conversely, researchers from the Novartis Institute for Biomedical Research found that anorexia and muscle loss, as complications in cancer, are mainly caused by increased levels of GDF-11, with GDF-15 being upregulated in response to supraphysiologic administration of GDF-11.